News

Novel Sensor Monitors Endograft Leaks Remotely


 

SCOTTSDALE, ARIZ. — Vascular interventionalists may soon routinely implant pressure sensors that can detect endoleaks during both thoracic and abdominal aneurysm repair.

“Remote pressure sensing for endovascular repair is feasible,” Dr. Ross Milner said at an international symposium on endovascular interventions sponsored by the Arizona Heart Foundation. The sensors have no battery. They are activated by energy waves generated by external probes, which also read the measurement.

In a recent publication, Dr. Milner, of the division of vascular surgery at Emory University, Atlanta, said there are two devices in development, one that uses ultrasound waves and the other, radio waves. Both devices—the ImPressure ultrasound device, Remon Medical Technologies Inc., and the Endosensor, CardioMEMS Inc.—have been implanted in human trials.

The Endosensor device was approved for U.S. marketing in November, based on a 12-center trial. In a report on the trial at the most recent Society for Vascular Surgery meeting, the investigators said the device was implanted in 70 patients undergoing endovascular repair of abdominal aortic aneurysms without complication. It accurately measured pressure in 65 of the patients and detected all 15 endoleaks that occurred during the procedure.

Dr. Milner and his colleagues at Emory have begun using the ImPressure device in thoracic aneurysm repairs, with the first implant done in Brazil last July. That device continued to function well 8 months after implantation, and it has shown a dramatic, continued drop in pulse pressure within the aneurysm sac.

He predicted that, in time, use of these pressure devices may omit the need for CT angiography at the end of procedures to be sure the graft has completely sealed off the aneurysm, thus sparing patients some exposure to contrast agent. “Pressure sensing will be feasible in the thoracic aorta and may add a lot to the follow-up of these patients as it allows for appropriate intraoperative exclusion as well as long-term follow-up,” he said. The sensors are compatible with any graft system, he added.

Recommended Reading

Strong Role Remains for Primary Lytics Early in MI
MDedge Cardiology
L-Arginine After MI Linked to Higher Mortality
MDedge Cardiology
Telemetry Spots Silent Arrythmia in Stroke Patients
MDedge Cardiology
From Early On, Diabetics Face Higher Stroke Risk
MDedge Cardiology
Cognition Improved by Carotid Artery Stenting : Faster cognition after stenting is related to improved blood perfusion to the brain, imaging study suggests.
MDedge Cardiology
New DES Platforms May Cut Thrombosis Risk
MDedge Cardiology
Nitinol Stents Safe, Effective in Femoral Arteries
MDedge Cardiology
Limited Abciximab in PCI May Facilitate Same-Day Release
MDedge Cardiology
Type A Aortic Dissection Calls for Experience
MDedge Cardiology
20-Year Study Confirms Benefits of MIMA Bypass : The long-term rates of adverse events are decreased, provided the grafts are placed on the two largest vessels.
MDedge Cardiology